How to buy Spectrum Pharmaceuticals stock (SPPI)

Spectrum Pharmaceuticals is a biotechnology & medical research business based in the US. Spectrum Pharmaceuticals shares (SPPI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.03 – the same closing value as a week prior. Spectrum Pharmaceuticals employs 86 staff and has a trailing 12-month revenue of around $25.7 million.

Our top picks for where to buy Spectrum Pharmaceuticals stock

Buy Spectrum Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Spectrum Pharmaceuticals stock price (NASDAQ: SPPI)

Use our graph to track the performance of SPPI stocks over time.

Spectrum Pharmaceuticals shares at a glance

• Key figures

Information last updated 2023-10-02.

Latest market close	$1.03
52-week range	$0.00 - $0.00
50-day moving average more info button	$1.02
200-day moving average more info button	$0.77
Wall St. target price	$1.14
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.36

Is it a good time to buy Spectrum Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Spectrum Pharmaceuticals price performance over time

Historical closes compared with the close of $1.03 from 2023-08-04

1 week (2024-09-30)	N/A
1 month (2024-09-07)	N/A
3 months (2024-07-07)	N/A
6 months (2024-04-07)	N/A

1 year (2023-10-07)	N/A
2 years (2022-10-11)	171.05%
3 years (2021-10-11)	1.99
5 years (2019-10-11)	7.505

Spectrum Pharmaceuticals financials

Revenue TTM	$25.7 million
Gross profit TTM	$8.3 million
Return on assets TTM	-38.21%
Return on equity TTM	-165.02%
Profit margin	-252.5%
Book value	$0.13
Market Capitalization more info button	$211.4 million

TTM: trailing 12 months

Spectrum Pharmaceuticals share dividends

We're not expecting Spectrum Pharmaceuticals to pay a dividend over the next 12 months.

Have Spectrum Pharmaceuticals's shares ever split?

Spectrum Pharmaceuticals's shares were split on a 1:25 basis on 5 September 2002. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Spectrum Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Spectrum Pharmaceuticals shares which in turn could have impacted Spectrum Pharmaceuticals's share price.

Spectrum Pharmaceuticals share price volatility

Over the last 12 months, Spectrum Pharmaceuticals's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spectrum Pharmaceuticals's is 2.1407. This would suggest that Spectrum Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Spectrum Pharmaceuticals overview

Spectrum Pharmaceuticals, Inc. , a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd. ; a patent and technology license agreement with The University of Texas M.

Frequently asked questions

What percentage of Spectrum Pharmaceuticals is owned by insiders or institutions?
Currently 11.002% of Spectrum Pharmaceuticals shares are held by insiders and 22.931% by institutions. How many people work for Spectrum Pharmaceuticals?
Latest data suggests 86 work at Spectrum Pharmaceuticals. When does the fiscal year end for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals's fiscal year ends in December. Where is Spectrum Pharmaceuticals based?
Spectrum Pharmaceuticals's address is: Pilot House ? Lewis Wharf, Boston, MA, United States, 02110 What is Spectrum Pharmaceuticals's ISIN number?
Spectrum Pharmaceuticals's international securities identification number is: US84763A1088 What is Spectrum Pharmaceuticals's CUSIP number?
Spectrum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 640656104